TKK Symphony Acquisition Corporation (TKKS) announced this morning that it would be extending the expiration of its tender offer to purchase up to 25,000,000 shares at a purchase price of $10.28 (plus accrued interest) for a SIXTH time. The tender offer will now expire at 5:00 p.m. New York City time, tomorrow, Wednesday, February 12, 2020, unless further extended or earlier terminated.
As for the status of their tender offer, TKKS disclosed that to-date, an aggregate of 24,987,171 ordinary shares have been tendered out of 25,000,000. That leaves 12,829 shares with an estimated trust value of approximately $132,523 (if we assume a current estimated per share trust value of $10.33). If you recall, at their last extension, 24,560,639 shares had been tendered. And at the extension prior to that one, 21,295,878 tendered. So their results are getting worse.
The reason given for the extension is, “The purpose of the extension is to provide additional time for the parties to close the transaction.” However, by extending only one day it’s going to be pretty difficult to change the current circumstances, so again, further extensions are not off the table. TKK Symphony’s completion deadline is February 20th, so anything is possible after six tender offer extensions.
Stay tuned…
AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...
At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...
Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...
At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...